{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:24:06Z","timestamp":1793953446507,"version":"4.8.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001732","name":"Danish National Research Foundation","doi-asserted-by":"publisher","award":["DNRF135"],"award-info":[{"award-number":["DNRF135"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsbergfondet","doi-asserted-by":"publisher","award":["CF23-1388"],"award-info":[{"award-number":["CF23-1388"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF23OC0081177"],"award-info":[{"award-number":["NNF23OC0081177"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omtn.2026.102866","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:14:27Z","timestamp":1770999267000},"page":"102866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimizing C14120-based LNPs for in vitro and in vivo mRNA delivery"],"prefix":"10.1016","volume":"37","author":[{"given":"Ping","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Lilly","family":"Kristine Vraa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gockert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Fjelstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Hager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4128-9317","authenticated-orcid":false,"given":"J\u00f8rgen","family":"Kjems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102866_bib1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtn.2026.102866_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41467-022-35637-z","article-title":"Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis","volume":"14","author":"Han","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102866_bib3","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1039\/D1CS00617G","article-title":"Emerging mRNA technologies: delivery strategies and biomedical applications","volume":"51","author":"Xiao","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.omtn.2026.102866_bib4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ymthe.2019.05.002","article-title":"Lipidoid-siRNA Nanoparticle-Mediated IL-1\u03b2 Gene Silencing for Systemic Arthritis Therapy in a Mouse Model","volume":"27","author":"Song","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102866_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc7804","article-title":"Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models","volume":"13","author":"Hotz","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.102866_bib6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102866_bib7","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S1470-2045(22)00372-2","article-title":"Clinical advances and ongoing trials of mRNA vaccines for cancer treatment","volume":"23","author":"Lorentzen","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omtn.2026.102866_bib8","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.omtn.2019.12.044","article-title":"Strong Immune Responses Induced by Direct Local Injections of Modified mRNA-Lipid Nanocomplexes","volume":"19","author":"Arya","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102866_bib9","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/0008-5472.CAN-18-2867","article-title":"Local Delivery of Ox40l, Cd80, and Cd86 mRNA Kindles Global Anticancer Immunity","volume":"79","author":"Haabeth","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2026.102866_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.102866_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41576-022-00559-5","article-title":"Navigating the pitfalls of mapping DNA and RNA modifications","volume":"24","author":"Kong","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2026.102866_bib12","article-title":"A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery","volume":"10","author":"Naidu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2026.102866_bib13","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.omtn.2026.102866_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102866_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acs.accounts.1c00601","article-title":"Non-liver mRNA Delivery","volume":"55","author":"Loughrey","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.omtn.2026.102866_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jconrel.2022.12.020","article-title":"Self-homing nanocarriers for mRNA delivery to the activated hepatic stellate cells in liver fibrosis","volume":"353","author":"Younis","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102866_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2026.102866_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102866_bib19","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41591-021-01490-8","article-title":"Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy","volume":"27","author":"Dagan","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.102866_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-021-01480-7","article-title":"BNT162b2 mRNA COVID-19 Vaccine: First Approval","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.omtn.2026.102866_bib21","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1038\/s41467-019-12275-6","article-title":"Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells","volume":"10","author":"Maugeri","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102866_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211420","article-title":"Optimizing Lipid Nanoparticles for Delivery in Primates","volume":"35","author":"Lam","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2026.102866_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2014.09.025","article-title":"Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration","volume":"196","author":"Chen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102866_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.copbio.2021.09.016","article-title":"Principles for designing an optimal mRNA lipid nanoparticle vaccine","volume":"73","author":"Kon","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102866_bib25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41565-021-01030-y","article-title":"Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles","volume":"17","author":"Hatit","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2026.102866_bib26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41551-023-01030-4","article-title":"Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery","volume":"7","author":"Rhym","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtn.2026.102866_bib27","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41467-024-45422-9","article-title":"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","volume":"15","author":"Xue","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102866_bib28","article-title":"A Nanoparticle Platform for Accelerated In Vivo Oral Delivery Screening of Nucleic Acids","volume":"4","author":"El-Mayta","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.omtn.2026.102866_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jconrel.2013.11.006","article-title":"The development of an in vitro assay to screen lipid based nanoparticles for siRNA delivery","volume":"174","author":"Zhang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102866_bib30","article-title":"Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.102866_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805308","article-title":"Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I","volume":"30","author":"Cheng","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtn.2026.102866_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309472120","article-title":"Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omtn.2026.102866_bib33","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1073\/pnas.1620874114","article-title":"Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics","volume":"114","author":"Dahlman","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omtn.2026.102866_bib34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jconrel.2023.04.005","article-title":"High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo","volume":"357","author":"Huayamares","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102866_bib35","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.nano.2016.12.014","article-title":"Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA","volume":"13","author":"Kulkarni","year":"2017","journal-title":"Nanomedicine."},{"key":"10.1016\/j.omtn.2026.102866_bib36","doi-asserted-by":"crossref","first-page":"28256","DOI":"10.1039\/D0CP05111J","article-title":"DOPC versus DOPE as a helper lipid for gene-therapies: molecular dynamics simulations with DLin-MC3-DMA","volume":"22","author":"Ermilova","year":"2020","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.omtn.2026.102866_bib37","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omtn.2026.102866_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.796991","article-title":"HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors","volume":"9","author":"Tan","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102866_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316759","article-title":"Effect of the Protein Corona Formation on Antibody Functionalized Liquid Lipid Nanocarriers","volume":"24","author":"Navarro-Marchal","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.102866_bib40","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/cells13050454","article-title":"Quantification of Polystyrene Uptake by Different Cell Lines Using Fluorescence Microscopy and Label-Free Visualization of Intracellular Polystyrene Particles by Raman Microspectroscopic Imaging","volume":"13","author":"Roth","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2026.102866_bib41","doi-asserted-by":"crossref","first-page":"15743","DOI":"10.1039\/D0NR01627F","article-title":"Quantifying the level of nanoparticle uptake in mammalian cells using flow cytometry","volume":"12","author":"Shin","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.omtn.2026.102866_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coviro.2021.03.008","article-title":"Future considerations for the mRNA-lipid nanoparticle vaccine platform","volume":"48","author":"Igy\u00e1rt\u00f3","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.omtn.2026.102866_bib43","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","article-title":"A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation","volume":"18","author":"Paunovska","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtn.2026.102866_bib44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102866_bib45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40824-023-00425-3","article-title":"mRNA nanodelivery systems: targeting strategies and administration routes","volume":"27","author":"Yuan","year":"2023","journal-title":"Biomater. Res."},{"key":"10.1016\/j.omtn.2026.102866_bib46","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2026.102866_bib47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.omtn.2026.102866_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omtn.2026.102866_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404684","article-title":"Discovery of Ketal-Ester Ionizable Lipid Nanoparticle with Reduced Hepatotoxicity, Enhanced Spleen Tropism for mRNA Vaccine Delivery","volume":"11","author":"Lv","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2026.102866_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103041","article-title":"Biological recognition and cellular trafficking of targeted RNA-lipid nanoparticles","volume":"85","author":"Escalona-Rayo","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102866_bib51","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1039\/D1BM01454D","article-title":"Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)","volume":"10","author":"\u00c1lvarez-Benedicto","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.omtn.2026.102866_bib52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41576-018-0008-z","article-title":"Heterogeneity and specialized functions of translation machinery: from genes to organisms","volume":"19","author":"Genuth","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2026.102866_bib53","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.omtn.2019.08.001","article-title":"Expression Kinetics and Innate Immune Response after Electroporation and LNP-Mediated Delivery of a Self-Amplifying mRNA in the Skin","volume":"17","author":"Huysmans","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102866_bib54","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102866_bib55","doi-asserted-by":"crossref","first-page":"zcac025","DOI":"10.1093\/narcan\/zcac025","article-title":"Differential RNA aptamer affinity profiling on plasma as a potential diagnostic tool for bladder cancer","volume":"4","author":"Fjelstrup","year":"2022","journal-title":"NAR Cancer"},{"key":"10.1016\/j.omtn.2026.102866_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb8786","article-title":"Transcriptomic and clonal characterization of T cells in the human central nervous system","volume":"5","author":"Pappalardo","year":"2020","journal-title":"Sci. Immunol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:16:56Z","timestamp":1780103816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126000375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2162253126000375"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102866","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing C14120-based LNPs for in vitro and in vivo mRNA delivery","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102866"}}